logo
Select company
Select metric
$ -5.59MNet Income Common Stock
VS
Market
40
Sector
74
Industry
87
History
35
$ 1Close
$ 0.83 - $ 1.92 52-Week Range
Ticker Information

Ticker

PMCB

Company Name

PHARMACYTE BIOTECH INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PHARMACYTE BIOTECH INC - Net Income Common Stock Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PMCB - Net Inc. Cmn. Historical data
DateNet Income Common Stock
6/30/2025$ -5.59M
3/31/2025$ 23.36M
12/31/2024$ 12.04M
9/30/2024$ 9.47M
6/30/2024$ 10.17M
3/31/2024$ -17.24M
12/31/2023$ -11.51M
9/30/2023$ -6.65M
6/30/2023$ -6.27M
3/31/2023$ -4.32M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Net Income Common Stock

[Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].

PMCB - Net Income Common Stock, Last 5 years

$ -17.24M

Minimum

Mar 31, 2024

$ 23.36M

Maximum

Mar 31, 2025

$ -1.92M

Average

$ -4.01M

Median

Net Inc. Cmn. Benchmark Analysis

The chart above depicts the distribution of Net Inc. Cmn. for companies in the Total Stock Market. The average Net Inc. Cmn. of the companies is $ 9.09M with a standard deviation of $ 113.35M.
The following table provides additional summary stats:
Net Inc. Cmn. in the Market:
filtered constituents3.36K
min$ -354.46M
max$ 366.08M
average$ 9.09M
median$ -2.42M
std$ 113.35M